SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,174 | -81.2% | 300 | -57.1% | 0.00% | -77.8% |
| Q2 2023 | $32,914 | +12.1% | 700 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $29,372 | +112869.2% | 700 | 0.0% | 0.01% | – |
| Q4 2022 | $26 | -99.9% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | +22.7% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -4.3% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -79.5% | 700 | -73.6% | 0.00% | – |
| Q4 2021 | $112,000 | -4.3% | 2,650 | 0.0% | 0.00% | – |
| Q3 2021 | $117,000 | -22.0% | 2,650 | 0.0% | 0.00% | – |
| Q2 2021 | $150,000 | -24.2% | 2,650 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $198,000 | -15.7% | 2,650 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $235,000 | +2.2% | 2,725 | -27.8% | 0.00% | – |
| Q3 2020 | $230,000 | +29.9% | 3,775 | -11.7% | 0.00% | – |
| Q2 2020 | $177,000 | +55.3% | 4,275 | +7.5% | 0.00% | – |
| Q1 2020 | $114,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |